Agilent - First Commercial Exome Target Enrichment Kit for Next-Generation Sequencing of a Model Organism
Agilent Technologies Signs Agreement to Acquire Assets of A2 Technologies; Deal to Expand Agilent’s Spectroscopy Portfolio
Semrock Patents Confirmed Following Reexamination

Agilent Technologies Signs Agreement to Acquire Assets of A2 Technologies; Deal to Expand Agilent’s Spectroscopy Portfolio

Agilent and A2 Technologies today announced they have signed a definitive agreement for Agilent to acquire specific assets of A2 Technologies. The acquisition includes substantially all of A2 Technologies’ intellectual property, technology, employees and its spectroscopy product portfolio. Subject to customary closing conditions, the transaction is expected to be final in mid-February. Financial details were not disclosed.

Headquartered in Danbury, Conn., privately held A2 Technologies focuses on Fourier transform infrared (FT-IR) technology for lab and field use. The company designs, develops and manufactures FT-IR spectrometers for routine analysis and out-of-lab applications in the petrochemical, environmental, aerospace, art conservation, academia and geosciences markets. A2 Technologies’ unique, patented technology offers customers high-performance analytical capabilities in a compact size.

A2 Technologies’ products, technology and people are a great fit with Agilent, said Mike McMullen, president of Agilent’s Chemical Analysis Group. We set out to grow our spectroscopy business, which we acquired this past year when Varian joined us, so we can offer customers an even wider range of the industry’s best solutions. Adding A2 Technologies’ cutting-edge, patented technology and top talent is a major move in this direction.

We are very excited about joining the Agilent team as we believe it will greatly benefit our employees and customers, said Jon Frattaroli, CEO and co-founder of A2 Technologies. For A2 Technologies, it will mean access to the many resources of Agilent, including their global distribution and support networks, as well as their innovative technology platforms. This will allow us to accelerate our growth, expand our support and bring even more exciting products to our customers.

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Previous Post

Agilent - First Commercial Exome Target Enrichment Kit for Next-Generation Sequencing of a Model Organism

Next Post

Semrock Patents Confirmed Following Reexamination